Granite Point Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-113	Closed	-$304K	–	133
2018 Q1	$304K	Buy	+113	New	+$304K	0.03%	83